🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 276 Beijing 6 Hangzhou 5 Wuhan 5 Qionghai 5
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281 Clear sponsor filter
Site location
Shanghai276 Beijing6 Hangzhou5 Wuhan5 Qionghai5
All 38 locations
Target enrolment
to
281 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy (Adebrelimab) Combined With Chemotherapy (XELOX): a Prospective, Single-center, Feasibility Study
NCT06482788Esophagogastric Junction Adenocarcinoma
Ruijin Hospital
Phase 2
26
Shanghai
2024-05-22
Recruiting
Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
NCT06541327Lymphoma, Non-Hodgkin
Ruijin Hospital
Observational
1,000
Shanghai
2024-05-15
Recruiting
Analysis of Deep Brain Nuclei LFP and Cortical EEG Signals During the Recovery From General Anesthesia
NCT06400901Deep Brain Stimulation Surgery, Electrophysiology, General Anesthesia, Consciousness, Loss of
Ruijin Hospital
Observational
42
Shanghai
2024-05-15
Recruiting
Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer
NCT06368141Colon Cancer
Ruijin Hospital
Phase 2
56
Shanghai
2024-05-01
Recruiting
An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).
NCT06339060Esophageal Cancer
Ruijin Hospital
Phase 3
356
Shanghai
2024-05-01
Recruiting
A Multimodal Prospective Cohort Study of Parkinsonism
NCT07553845Parkinsonism, REM Sleep Behavior Disorder
Ruijin Hospital
Observational
640
Shanghai
2024-05-01
Recruiting
Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients
NCT06404697Breast Cancer
Ruijin Hospital
Phase 2
24
Shanghai
2024-05
Recruiting
Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression
NCT06269211Carcinoma, Non-Small-Cell Lung
Ruijin Hospital
Phase 2
29
Guangzhou, Shanghai
2024-04-20
Recruiting
CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors
NCT06365671B-cell Non Hodgkin Lymphoma
Ruijin Hospital
Phase 2
16
Shanghai
2024-04-16
Recruiting
Effect of Belimumab on Antibody Titers in Primary APS Patients
NCT06747312Antiphospholipid Syndrome (APS)
Ruijin Hospital
Phase 2
20
Shanghai
2024-04-01
Not yet open
Cognitive Impairment Cohort Study of the Elderly Population in YuGarden
NCT06325527Alzheimer Disease, Neurodegenerative Diseases, Cognitive Impairment, Mild Cognitive Impairment
Ruijin Hospital
Observational
1,872
Shanghai
2024-04-01
Recruiting
a Feasibility Study of iHD-SRT for BM
NCT06231186Brain Metastases, Adult, Stereotactic Radiotherapy
Ruijin Hospital
Not applicable
35
Shanghai
2024-03-15
Not yet open
The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma
NCT06255795Extranodal Natural Killer T Cell Lymphoma
Ruijin Hospital
Phase 3
142
Shanghai
2024-02-15
Recruiting
A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML
NCT06329999Recurrent Adult Acute Myeloid Leukemia, Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia
Ruijin Hospital
Not applicable
78
Shanghai
2024-02-03
Recruiting
Toripalimab Combined With Definitive CCRT for LACC Patients
NCT06256224Cervical Cancer, Chemoradiotherapy, Immunotherapy
Ruijin Hospital
Not applicable
150
Shanghai
2024-02-02
Active, closed
12-Month Real-World Safety & Efficacy of Lecanemab in Early Alzheimer's Disease
NCT07034222Alzheimer's Disease(AD)
Ruijin Hospital
Phase 4
80
Shanghai
2024-02-01
Active, closed
Ultrasound Assessment of Isolated Distal Deep Vein Thrombosis
NCT06596941Iddvt, Pulmonary Embolism (PE)
Ruijin Hospital
Observational
800
Shanghai
2024-01-01
Recruiting
Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors
NCT05916248Advanced Solid Tumor
Ruijin Hospital
Phase EARLY_PHASE1
34
Shanghai
2023-12-20
Recruiting
PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma
NCT06069830NK-T-Cell Lymphoma, Extranodal
Ruijin Hospital
Not applicable
89
Shanghai
2023-12-06
Recruiting
Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma
NCT06876688CNS Lymphoma
Ruijin Hospital
Phase 2
30
Beijing, Guangzhou, Henan, Shanghai, Wuhan
2023-11-30
Recruiting
A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma
NCT06136351Lymphoma, Mantle-Cell
Ruijin Hospital
Phase 2
23
Shanghai
2023-11-15
Not yet open
Selinexor Combined With R-GDP Regimen for TP53-altered R/R DLBCL
NCT06062641Relapsed or Refractory B-cell Lymphoma
Ruijin Hospital
Phase 2
50
Shanghai
2023-10-30
Recruiting
De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC
NCT06572514Locally Advanced Head and Neck Squamous Cell Carcinoma
Ruijin Hospital
Phase 1/2
20
Shanghai
2023-10-17
Recruiting
Real-World Study of DLBCL With Different Genetic Subtypes
NCT06026488DLBCL - Diffuse Large B Cell Lymphoma, Lymphoma
Ruijin Hospital
Observational
10,000
Shanghai
2023-10-01
Recruiting
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
NCT06534489Non-small Cell Lung Cancer, Surgery
Ruijin Hospital
Observational
50
Shanghai
2023-08-31
Recruiting
Artificial Intelligence (AI) Analysis of Synchronized Phonocardiography (PCG) and Electrocardiogram(ECG)
NCT06009718Heart Failure
Ruijin Hospital
Observational
3,000
Shanghai
2023-08-25
Recruiting
Regional Lymph Node Irradiation for High-risk pN0 Breast Cancer
NCT05976412Breast Cancer
Ruijin Hospital
Not applicable
1,355
Shanghai
2023-07-28
Recruiting
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
NCT06074692Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone
Ruijin Hospital
Phase 2
86
Shanghai
2023-06-01
Recruiting
A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL
NCT05899621Follicular Lymphoma
Ruijin Hospital
Observational
332
Shanghai
2023-06-01
Recruiting
Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial
NCT06114225Osteosarcoma
Ruijin Hospital
Phase 2
43
Shanghai
2023-06-01
Recruiting
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
NCT05662540NK/T-cell Lymphoma
Ruijin Hospital
Not applicable
40
Shanghai
2023-05-26
Recruiting
Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease
NCT05887674Mild Cognitive Impairment, Mild Dementia
Ruijin Hospital
Not applicable
180
Shanghai
2023-05-11
Recruiting
Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma
NCT05806580Relapsed or Refractory B-cell Lymphoma
Ruijin Hospital
Phase 4
8
Shanghai
2023-05-01
Not yet open
Real World Study of Linperlisib for Lymphoma Treatment
NCT05863871Focus on the Lymphoma Including B/T-cell Lymphoma
Ruijin Hospital
Observational
1,000
Shanghai, Tianjin
2023-05
Recruiting
Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
NCT05916261Advanced Pancreatic Cancer
Ruijin Hospital
Phase EARLY_PHASE1
54
Qionghai
2023-04-26
Recruiting
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
NCT05870969Carcinoma, Hepatocellular, Hepatitis C, Chronic, Hepatitis B, Chronic, Cirrhosis, Liver
Ruijin Hospital
Observational
20,000
Shanghai
2023-03-01
Active, closed
Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE)
NCT05694065Ischemic Heart Disease
Ruijin Hospital
Observational
112
Shanghai
2023-02-17
Recruiting
Genotype-guided Treatment in Newly Diagnosed PTCL
NCT05675813Peripheral T Cell Lymphoma
Ruijin Hospital
Phase 1/2
264
Shanghai
2023-02-13
Recruiting
SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer
NCT05576480Rectal Cancer, Locally Advanced
Ruijin Hospital
Phase 2
55
Shanghai
2023-02-06
Recruiting
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in PANCEATIC Cancer (ASCEND-PANCREATIC)
NCT05556603Cancer
Ruijin Hospital
Observational
7,062
Shanghai
2022-12-28
Not yet open
Cognitive Impairment Cohort Study of the Elderly Population in SheMountain
NCT05667935Alzheimer Disease, Dementia, Neurodegenerative Diseases, Cognitive Impairment
Ruijin Hospital
Observational
2,000
Shanghai
2022-12-26
Recruiting
Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma
NCT06122493Esophageal Squamous Cell Carcinoma
Ruijin Hospital
Phase 2
48
Shanghai
2022-11-01
Recruiting
Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
NCT04973293Lung Neoplasm Malignant
Ruijin Hospital
Not applicable
20
Shanghai
2022-10-01
Recruiting
Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer
NCT05557552Non-small Cell Lung Cancer Stage III
Ruijin Hospital
Not applicable
56
Shanghai
2022-09-30
Recruiting
Cell Free DNA in Mature B-cell Lymphoma
NCT04088422Mature B-Cell Lymphoma
Ruijin Hospital
Observational
320
Shanghai
2022-09-28
Not yet open
Long Term Prospective Study of Tai Chi Intervention to Delay the Progression of Subjective Cognitive Impairment
NCT05485025Subjective Cognitive Impairment
Ruijin Hospital
Not applicable
134
Shanghai
2022-09
Active, closed
The Effectiveness and Safety of TMF in the Treatment of Chronic Hepatitis B Patients With Normal ALT.
NCT05797714HBV Infection, Chronic Hepatitis b
Ruijin Hospital
Not applicable
200
Changsha, Beijing, Dongyang, Fuyang, Hangzhou, Lishui, Nanchang, Nanjin
2022-06-08
Active, closed
A Multi-center Retrospective Study of INO Treating B-ALL
NCT07238907Acute Lymphoblastic Leukaemia, Acute Lymphoblastic Leukaemias (ALL), Inotuzumab Ozogamicin, Venetoclax
Ruijin Hospital
Observational
102
Shanghai
2022-06-01
Recruiting
Novel Targeted Drugs Combined With R-ICE Regimen in Relapsed and Refractory Diffuse Large B-cell Lymphoma
NCT05348213Diffuse Large B Cell Lymphoma
Ruijin Hospital
Phase 2
76
Shanghai
2022-05-16
Recruiting
A Follow-up Study of Asymptomatic Infections and Diagnosed Patients With Covid-19 in Shanghai
NCT05387304COVID-19
Ruijin Hospital
Observational
250,000
Shanghai
2022-03-29
Recruiting
Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients
NCT05277688Cervical Cancer
Ruijin Hospital
Phase 3
340
Shanghai
2022-03-15
Recruiting
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
NCT05597410Alzheimer Disease, Dementia, Neurodegenerative Diseases, Cognitive Impairment
Ruijin Hospital
Observational
3,418
Shanghai
2022-03-01
By invitation
TRIM25 in Septic Patients
NCT07320638Sepsis
Ruijin Hospital
Observational
65
Shanghai
2021-12-10
Recruiting
Ruijin Neurobank of Alzheimer's Disease and Dementia
NCT05623124Dementia
Ruijin Hospital
Observational
400
Shanghai
2021-11-22
Recruiting
The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With DLBCL in Low Risk
NCT05018520Diffuse Large B Cell Lymphoma
Ruijin Hospital
Phase 3
640
Shanghai
2021-09-17
Not yet open
Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer
NCT04384601Gastric Cancer, Neoadjuvant Chemotherapy
Ruijin Hospital
Phase 3
246
Shanghai
2021-09
Recruiting
Spinal Cord Stimulation for Parkinsonism
NCT05171205Parkinsonism
Ruijin Hospital
Not applicable
50
Shanghai
2021-05-01
Recruiting
Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study
NCT06708130Allogeneic Hematopoietic Stem Cell Transplantation
Ruijin Hospital
Observational
3,000
Shanghai
2021-05-01
Recruiting
Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer
NCT04527861Colorectal Cancer, Colon Cancer, Rectal Cancer
Ruijin Hospital
Not applicable
710
Lanzhou, Shenyang, Jinan, Chengdu, Hangzhou, Shanghai
2021-04-08
Recruiting
Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer
NCT04517266Breast Cancer
Ruijin Hospital
Not applicable
214
Shanghai
2021-03-01
Recruiting
Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy
NCT05552846Small-cell Lung Cancer
Ruijin Hospital
Not applicable
104
Shanghai
2021-01-30
Active, closed
Super Hypofractionated Irradiation for Whole Breast Treatment
NCT04926766Breast Cancer
Ruijin Hospital
Not applicable
217
Shanghai
2021-01-23
Active, closed
Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer
NCT04509648Breast Cancer
Ruijin Hospital
Not applicable
197
Shanghai
2021-01-21
Recruiting
The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)
NCT04858724IgA Nephropathy
Ruijin Hospital
Observational
2,000
Shanghai
2020-12-01
Recruiting
Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer
NCT05140746Gastric Cancer
Ruijin Hospital
Not applicable
40
Shanghai
2020-09-10
Active, closed
A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies
NCT04534023Rapid Eye Movement Sleep Behavior Disorder, Synucleinopathy
Ruijin Hospital
Phase 2
28
Shanghai
2020-08-31
Active, closed
Zanubrutinib, Lenalidomide and Rituximab (ZR2) in Elderly Treatment-naive Patients With Diffuse Large B-cell Lymphoma (DLBCL)
NCT04460248Diffuse Large B Cell Lymphoma
Ruijin Hospital
Phase 2
40
Shanghai
2020-08-26
Recruiting
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
NCT06534658Alzheimer Disease, Image
Ruijin Hospital
Observational
1,000
Beijing, Hanzhong, Cangzhou, Shijiazhuang, Qingdao, Shanghai, Shenyang
2020-07-30
Not yet open
RAMPS VS SRPS for Pancreatic Body and Tail Adenocarcinoma
NCT04253847Radical Antegrade Modular Pancreatosplenectomy
Ruijin Hospital
Not applicable
224
Shanghai
2020-02-15
Active, closed
Perioperative Treatment of Combined SOX With Apatinib and Camrelizumab for Oesophagogastric Cancer
NCT04208347Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
Ruijin Hospital
Phase 2/3
580
Baoding, Beijing, Changsha, Changzhi, Chengdu, Guiyang, Haikou, Hangzhou
2019-12-18
Active, closed
A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center
NCT06949241Pemphigus Disease, Rituximab (RTx), Intravenous Immunoglobulin
Ruijin Hospital
Observational
76
Shanghai
2019-12-01
Recruiting
BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma
NCT04072042Sarcoma
Ruijin Hospital
Phase 2
30
Shanghai
2019-10-30
Active, closed
Quantitative Flow Ratio (QFR) Guided Coronary Artery Bypass Grafting for Patients Undergoing Primary Valve Surgery With Concomitant Coronary Artery Disease
NCT03977129Primary Valvular Heart Disease With Comorbid Coronary Artery Disease, Planned to Undergo Elective On-pump Valve Surgery Due to Primary Mitral and/or Aortic Valvular Heart Disease
Ruijin Hospital
Not applicable
792
Hefei, Fuzhou, Zhengzhou, Changsha, Jinan, Qingdao, Shanghai, Tianjin
2019-08-04
Recruiting
Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment
NCT03829553Breast Cancer
Ruijin Hospital
Phase 3
801
Shanghai
2019-02-21
Recruiting
Study of High Efficient Killing Cell Therapy for Advanced NSCLC
NCT03193567Non Small Cell Lung Cancer
Ruijin Hospital
Phase 1
15
Shanghai
2017-09-14
Recruiting
Metabolic Abnormalities, Lifestyle and Diet Pattern in Heart Failure
NCT03951311Heart Failure, Metabolic Disease
Ruijin Hospital
Observational
1,500
Shanghai
2016-06-01
Recruiting
Risk Evaluation and Management in Heart Failure
NCT02998788Heart Failure, Risk Factor, Cardiovascular
Ruijin Hospital
Observational
1,000
Shanghai
2016-06
Recruiting
PRogression of Atheroma Evaluated by CT Angiography and IntraCoronary Imaging tEchniques
NCT06794684Coronary Arterial Disease (CAD), Coronary Arteriosclerosis
Ruijin Hospital
Observational
50,000
Shanghai
2016-01-01
Recruiting
Cardiometabolic evalUation REgistry of Heart Failure
NCT06939985Heart Failure, Metabolic Cardiovascular Syndrome, Metabolic Diseases
Ruijin Hospital
Observational
5,000
Shanghai
2015-01-01
Recruiting
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
NCT06795113Lymphoma
Ruijin Hospital
Observational
4,000
Shanghai
2013-06-01
Recruiting
Risk Factors and Outcomes in Coronary Chronic Total Occlusion
NCT06137521Chronic Total Occlusion, Coronary Artery Disease
Ruijin Hospital
Observational
3,000
Shanghai
2010-01-01
Rows per page Showing 201–281 of 281
Previous 1 2 3
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=3

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.